(PubMed) Ren X, Xu P, Zhang D, et al
S.ShahiU
Jin X, Li L, Peng Q, Gan C, Gao L, He S, et al
For example, the spacer can be selected from the group consisting of -C1-C10 alkylene- , -C1-C10 heteroalkylene-, -C3-C8 carbocyclo-, -O-(Ci Cs alkyl)-, -arylene-, -C1-C10 alkylene-arylene-, -arylene-C-i-C-io alkylene-, -C1-C10 alkylene-(C3-Cs carbocyclo)-, -(C3- Cs carbocyclo)-Ci-Cio alkylene-, -C3-C8 heterocyclo-, -C1-C10 alkylene-(C3- Cs heterocyclo)-, -(C3-C8 heterocyclo)-Ci-Cio alkylene-, -C1-C10 alkylene-C(=O)-, -C1- C10 heteroalkylene-C(=O)-, -C3-C8 carbocyclo-C(=O)-, -O-(Ci-Cs alkyl)-C(=O)-, -arylene- C(=O)-, -C1-C10 alkylene-arylene-C(=O)-, -arylene-Ci-Cw alkylene-C(=O)-, -C1- C10 alkylene-(C3-C8carbocyclo)-C(=O)-, -(C3-C8 carbocyclo)-Ci-Cio alkylene-C(=O)-, - C3-C8 heterocyclo-C(=O)-, -C1-C10 alkylene-(C3-C8heterocyclo)-C(=O)-, -(C3- Cs heterocyclo)-Ci-Cio alkylene-C(=O)-, -C1-C10 alkylene-NH-, -C1-C10 heteroalkylene- NH-, -C3-C8 carbocyclo-NH-, -O-(Ci-Cs alkyl)-NH-, -arylene-NH-, -C1-C10 alkylene- arylene-NH-, -arylene-Ci-Cw alkylene-NH-, -C1-C10 alkylene-(C3-Cs carbocyclo)-NH-, - (C3-C8 carbocyclo)-Ci-Cio alkylene-NH-, -Cs-Csheterocyclo-NH-, -C1-C10 alkylene-(C3- Cs heterocyclo)-NH-, -(C3-C8 heterocyclo)-Ci-Cio alkylene-NH-, -Ci-Cwalkylene-S-, -C1- C10 heteroalkylene-S -, -Cs-Cscarbocyclo-S -, -O-(Ci-Cs alkyl)-)-S -, -arylene-S-, -C1-C10 alkylene-arylene-S-, -arylene-Ci-Cw alkylene-S-, -Ci-Cio alkylene-(C3-Cs carbocyclo)-S- , -(C3-C8 carbocyclo)-Ci-Cio alkylene-S-, -C3-C8 heterocyclo-S-, -C1-C10 alkylene-(C3- Cs heterocyclo)-S-, -(C3-C8 heterocyclo)-Ci-Cio alkylene-S-, -C1-C10 alkylene-O-C(=O)-, -C3-C8 carbocyclo-O-C(=O)-, -O-(Ci-Cs alkyl)-O-C(=O)-, -arylene-O-C(=O)-, -C1- C10 alkylene-arylene-O-C(=O)-, -arylene-Ci-Cw alkylene-O-C(=O)-, -C1-C10 alkylene- (C3-C8carbocyclo)-O-C(=O)-,-(C3-C8 carbocyclo)-Ci-Cio alkylene-O-C(=O)-, -C3- Cs heterocyclo-O-C(=O)-, -C1-C10 alkylene-(C3-C8heterocyclo)-O-C(=O)-, and -(C3- Cs heterocyclo)-Ci-Cio alkylene-O-C(=O)-
In the course of the present study, the following inhibitors of glutamate dehydrogenase were identified: epigallocatechin-3-gallate (EGCG), hexachlorophene (HCP), bithionol (BTH), GW5074, CPD-3B, ebselenin, R162, and others(Table 3)
Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance
